Development of a multivariate model to predict significant coronary artery disease in Thai patients with left ventricular systolic dysfunction and determine the applicability of coronary angiography: a single-center, retrospective, case–control study

[1] Felker GM, Shaw LK, O’Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002; 39:210–8.FelkerGMShawLKO’ConnorCMA standardized definition of ischemic cardiomyopathy for use in clinical researchJ Am Coll Cardiol200239210–810.1016/S0735-1097(01)01738-7Search in Google Scholar

[2] Sisakian H. Cardiomyopathies: evolution of pathogenesis concepts and potential for new therapies. World J Cardiol. 2014; 6:478–94.SisakianHCardiomyopathies: evolution of pathogenesis concepts and potential for new therapiesWorld J Cardiol20146478–9410.4330/wjc.v6.i6.478Search in Google Scholar

[3] Malcom J, Arnold O, Howlett JG, Ducharme A, Ezekowitz JA, Gardner M, et al. Canadian Cardiovascular Society Consensus Conference Guidelines on Heart Failure 2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol. 2008; 24:21–40.MalcomJArnoldOHowlettJGDucharmeAEzekowitzJAGardnerMet alCanadian Cardiovascular Society Consensus Conference Guidelines on Heart Failure 2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesCan J Cardiol20082421–4010.1016/S0828-282X(08)70545-2Search in Google Scholar

[4] Wexler RK, Elton T, Pleister A, Feldman D. Cardiomyopathy: an overview. Am Fam Physician. 2009; 79:778–84.WexlerRKEltonTPleisterAFeldmanDCardiomyopathy: an overviewAm Fam Physician200979778–84Search in Google Scholar

[5] Pinto N, Haluska B, Mundy J, Griffin R, Wood A, Shah P. Ischemic cardiomyopathy: midterm survival and its predictors. Asian Cardiovasc Thorac Ann. 2012; 20:669–74.PintoNHaluskaBMundyJGriffinRWoodAShahPIschemic cardiomyopathy: midterm survival and its predictorsAsian Cardiovasc Thorac Ann201220669–7410.1177/021849231244250923284108Search in Google Scholar

[6] Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, et al. Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction. J Am Coll Cardiol. 2014; 64:553–61. Erratum in J Am Coll Cardiol. 2014; 64:1539.PanzaJAVelazquezEJSheLSmithPKNicolauJCFavaloroRRet alExtent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunctionJ Am Coll Cardiol201464553–61. Erratum in J Am Coll Cardiol. 2014; 64:153910.1016/j.jacc.2014.04.064Search in Google Scholar

[7] Romero-Farina G, Candell-Riera J, Aguadé-Bruix S, Castell-Conesa J, de Léon G, Igual A. Predictors of improved left ventricular systolic function after surgical revascularization in patients with ischemic cardiomyopathy. Rev Esp Cardiol. 2007; 60:943–51.Romero-FarinaGCandell-RieraJAguadé-BruixSCastell-ConesaJdeLéon GIgualAPredictors of improved left ventricular systolic function after surgical revascularization in patients with ischemic cardiomyopathyRev Esp Cardiol200760943–5110.1157/1310964717915150Search in Google Scholar

[8] Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med. 2012; 19:403–88.PerkJDeBacker GGohlkeHGrahamIReinerZVerschurenWMet alEuropean Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012)The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med201219403–8810.1007/s12529-012-9242-523093473Search in Google Scholar

[9] Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB Sr, Gibbons R, et al. 2013 ACC/ AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63:2935–59.GoffDC JrLloyd-JonesDMBennettGCoadySD’AgostinoRB SrGibbonsRet al2013 ACC/ AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/ American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol2014632935–5910.1161/01.cir.0000437741.48606.9824222018Search in Google Scholar

[10] Whellan DJ, Tuttle RH, Velazquez EJ, Shaw LK, Jollis JG, Ellis W, et al. Predicting significant coronary artery disease in patients with left ventricular dysfunction. Am Heart J. 2006; 152:340–7.WhellanDJTuttleRHVelazquezEJShawLKJollisJGEllisWet alPredicting significant coronary artery disease in patients with left ventricular dysfunctionAm Heart J2006152340–710.1016/j.ahj.2005.12.00116875920Search in Google Scholar

[11] Wongchareon W, Phrommintikul A, Kanjanavanit R, Kuanprasert S, Sukonthasarn A. A predictive model for distinguishing ischemic from non-ischemic cardiomyopathy. J Med Assoc Thai. 2005; 88:1689–96.WongchareonWPhrommintikulAKanjanavanitRKuanprasertSSukonthasarnAA predictive model for distinguishing ischemic from non-ischemic cardiomyopathyJ Med Assoc Thai2005881689–96Search in Google Scholar

[12] Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 focused update incorporated into the ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008; 52:e1–142.BonowROCarabelloBAChatterjeeKdeLeon AC JrFaxonDPFreedMDet al2008 focused update incorporated into the ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease)Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol200852e1–142Search in Google Scholar

[13] Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 60:e44–164.FihnSDGardinJMAbramsJBerraKBlankenshipJCDallasAPet al2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsJ Am Coll Cardiol201260e44–16410.1161/CIR.0b013e318277d6a0Search in Google Scholar

[14] Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004; 110:227–39. Erratum in: Circulation. 2004; 110:763.GrundySMCleemanJIMerzCNBrewerHB JrClarkLTHunninghakeDBet alImplications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelinesCirculation2004110227–39. Erratum in: Circulation. 2004; 110:76310.1161/01.CIR.0000133317.49796.0ESearch in Google Scholar

[15] Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. Cardiol Clin. 2014; 32:439–55.AronsonDEdelmanERCoronary artery disease and diabetes mellitusCardiol Clin201432439–5510.1016/j.ccl.2014.04.001467294525091969Search in Google Scholar

[16] Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999; 99:1165–72.JousilahtiPVartiainenETuomilehtoJPuskaPSex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in FinlandCirculation1999991165–7210.1161/01.CIR.99.9.116510069784Search in Google Scholar

[17] Niedziela J, Hudzik B, Niedziela N, Gąsior M, Gierlotka M, Wasilewski J, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014; 29:801–12.NiedzielaJHudzikBNiedzielaNGąsiorMGierlotkaMWasilewskiJet alThe obesity paradox in acute coronary syndrome: a meta-analysisEur J Epidemiol201429801–1210.1007/s10654-014-9961-9Search in Google Scholar

[18] Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002; 39:578–84.GrubergLWeissmanNJWaksmanRFuchsSDeibleRPinnowEEet alThe impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol200239578–8410.1016/S0735-1097(01)01802-2Search in Google Scholar

[19] Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015; 115:1428–34.SharmaALavieCJBorerJSVallakatiAGoelSLopez-JimenezFet alMeta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failureAm J Cardiol20151151428–3410.1016/j.amjcard.2015.02.02425772740Search in Google Scholar

[20] Numasawa Y, Kohsaka S, Miyata H, Kawamura A, Noma S, Suzuki M, et al. Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry. PLoS One. 2015; 10:e0124399. 10.1371/journal.pone.0124399.NumasawaYKohsakaSMiyataHKawamuraANomaSSuzukiMet alImpact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registryPLoS One201510e012439910.1371/journal.pone.0124399439704625874887Open DOISearch in Google Scholar

[21] Neeland IJ, Kontos MC, de Lemos JA. Evolving considerations in the management of patients with left bundle branch block and suspected myocardial infarction. J Am Coll Cardiol. 2012; 60:96–105.NeelandIJKontosMCdeLemos JAEvolving considerations in the management of patients with left bundle branch block and suspected myocardial infarctionJ Am Coll Cardiol20126096–10510.1016/j.jacc.2012.02.054340216222766335Search in Google Scholar